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ABSTRACT Genome-wide association studies (GWAS) have been successfully applied in humans for the
study of many complex phenotypes. However, identification of the genetic determinants of hearing in
adults has been hampered, in part, by the relative inability to control for environmental factors that might
affect hearing throughout the lifetime, as well as a large degree of phenotypic heterogeneity. These and
other factors have limited the number of large-scale studies performed in humans that have identified
candidate genes that contribute to the etiology of this complex trait. To address these limitations, we
performed a GWAS analysis using a set of inbred mouse strains from the Hybrid Mouse Diversity Panel.
Among 99 strains characterized, we observed approximately two-fold to five-fold variation in hearing at six
different frequencies, which are differentiated biologically from each other by the location in the cochlea
where each frequency is registered. Among all frequencies tested, we identified a total of nine significant
loci, several of which contained promising candidate genes for follow-up study. Taken together, our results
indicate the existence of both genes that affect global cochlear function, as well as anatomical- and
frequency-specific genes, and further demonstrate the complex nature of mammalian hearing variation.
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Genome-wide association studies (GWAS) have been successfully ap-
plied to numerous complex traits in humans (Welter et al. 2014). These
GWAS leverage natural genetic variation in an unbiased approach
that is advantageous for studying complex traits. We and others have
shown that audiometric threshold elevation secondary to aging in hu-
mans is continuously distributed throughout the population (Friedman
et al. 2009) and that the human cochlea has a perceptual frequency
spectrum of 20 Hz to 20 kHz. Heritability studies have shown that
the sources of this variance are both genetic and environmental, with
approximately half of the variance attributable to hereditary factors
(Huang and Tang 2010). As such, a major impediment to progress
in the discovery of risk loci for hearing in humans is the lack of con-
trol of the many environmental factors that affect hearing during the
lifetime, and, to date, only a limited number of large-scale GWAS for
hearing phenotypes have been undertaken in humans. We recently
reported an association between age-related hearing loss and SNPs
within the GRM7 gene and subsequently demonstrated, in a more
comprehensive study, the polygeneic nature of this disease (Fransen
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et al. 2015). Despite these successes, association studies in humans
(particularly for common forms of hearing loss and baseline hearing
ability) are still plagued by small sample sizes and phenotypic hetero-
geneity.
To harness the same investigative power of the GWAS approach in
a more controlled environment that addresses some limitations of
human studies, several groups have proposed mouse GWAS (Valdar
et al. 2006; Bennett et al. 2010; Flint and Eskin 2012; Ghazalpour et al.
Figure 1 Variation in ABR in the HMDP. The auditory brainstem response (ABR) to tone burst stimuli at six different frequencies exhibits two-fold
to five-fold variation among 99 HMDP strains. Each dot represents an individual mouse from the respective strain and the mean values are
indicated by the horizontal black bars. Female 5-wk-old mice were exposed to auditory signals at frequencies of 4 kHz, 8 kHz, 12 kHz, 16 kHz, 24 kHz,
and 32 kHz. The ability of individual mice to hear these signals was assessed using an ABR test. ABR is represented by the decibel level at which
hearing threshold was reached, determined visually by an ABR waveform.
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2012; Mott and Flint 2013). For obvious reasons, mouse models have
several advantages over human studies. The environment can be more
carefully controlled, measurements can be replicated in genetically
identical animals, and the proportion of the variability explained by
genetic variation is increased. Complex traits in mouse strains have
been shown to have higher heritability, and genetic loci often have
stronger effects on the trait compared to humans (Lindblad-Toh
et al. 2000; Wiltshire et al. 2003; Yalcin et al. 2004). Furthermore,
several recently developed strategies for mouse genetic studies, such
as use of the Hybrid Mouse Diversity Panel (HMDP), provide much
higher resolution for associated loci than traditional approaches with
quantitative trait loci (QTL) mapping (Bennett et al. 2010; Ghazalpour
Figure 1 Continued.
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Figure 2 Manhattan plots of GWAS results for ABR at each tone burst frequency. (A) ABR at 4 kHz was significantly associated with a locus on
chromosome 9 and a region on chromosome 19. (B) A GWAS for the 8-kHz tone burst revealed two significantly associated loci on chromosomes 10
and 19. (C) Three significantly associated loci on chromosomes 3, 13, and 19 were identified in the GWAS analysis for the 12-kHz tone burst. (D) One
significant locus on chromosome 10 was associated with ABR at the 16-kHz tone burst. (E) The GWAS for ABR at 24 kHz identified two different
significant loci on chromosome 13. (F) Two significant loci on chromosomes 4 and 13 were associated with ABR at 32 kHz. For each significantly
associated locus, the gene(s) nearest to the peak SNP is indicated. The GWAS analyses for each of the six tone burst stimuli included 182,270 SNPs,
whose genomic positions are shown along the x-axis with their corresponding -log10 P values indicated by the y-axis. The genome-wide thresholds
for significant (P=4.1·1026) and suggestive (P=4.1·1024) evidence of association are indicated by the horizontal red and blue lines, respectively.
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et al. 2012). The genetic and functional similarities of the mouse and
human ear coupled with the ability to control environmental exposure
make themouse the ideal model for the study of age-related hearing loss.
Both naturally occurring and experimentally induced mutations in
mice have providedmuchof our current understanding ofmanydiseases
of the ear. It has long been our hypothesis that common forms of hearing
impairment in both mice and humans is a complex trait resulting from
susceptibility loci throughout the genome that contribute to the natural
variation in hearing over time. Based on literature suggesting that most
common disease phenotypes result from sequence variation, often
regulatory, in genes that are different from those underlyingMendelian
traits, e.g., nonsyndromic hearing loss, we undertook a study to char-
acterize the genetics of hearing by performing an association analysis
that exploits the natural genetic and phenotypic variation of hearing
levels in inbred strains of mice.
MATERIALS AND METHODS
Animals
Female 5-wk-old mice of 99 inbred strains (n = 3–8) from the HMDP
(Jackson Laboratories) were obtained and used in accordance with
the University of Southern California Institutional Animal Care and
Use Committee (IACUC) guidelines. Mice were housed in sterilized
microisolator cages and received autoclaved food and water ad libitum.
Hearing assessment using auditory brainstem response
thresholds (ABR)
Mice were anesthetized with an intraperitoneal injection of amixture of
ketamine (80mg/kg bodyweight) and xylazine (16mg/kg bodyweight).
Mouse body temperature was maintained through the use of a TCAT-
2DF temperature controller and the HP-4 M heating plate (Physitemp
Instruments Inc., Clifton,NJ).Artificial tear ointmentwas applied to the
eyes during anesthesia. Finally, mice recovered from anesthesia on
a heating pad. Stainless-steel electrodes were placed subcutaneously
at the vertex of the head and the left mastoid. A ground electrode was
placed at the base of the tail. Test sounds were presented using an
IntelligentHearing Systems speaker attached toan8-inch-long tube that
was inserted into the ear canal. Due to time and equipment constraints,
only the left ear was assessed.
Auditorysignalswerepresentedas tonepips (4,8, 16, 24, and32kHz)
in the formof ahammingwavewitha0.3-msrise and fall time(total time
of 1 ms). These signals were presented at a rate of 40 per second. They
were then sent to an amplifier and then to the sound transducer from
IntelligentHearing Systems. Physiologic responseswere recordedwith a
20,000 analog-to-digital rate and sent to an eight-channel 150-gain AC/
DC headbox, and then onto a secondary Synamps signal amplifier of
2500 gain before analysis. Filter settingswere set at a lowpass of 3000Hz
and a high pass of 100 Hz with an artifact rejection of signals with
amplitudes exceeding650 mV. Three thousand waveforms were aver-
aged at each stimulus intensity. Tone bursts were first presented at
a high intensity to elicit a waveform. Next, the intensity was decreased
by 20 dB until nearing threshold. Intensity was then decreased in
smaller steps of 10, 5, and 2 dB as threshold was approached. Hearing
threshold was determined by visual inspection of ABR waveforms and
was defined as the intensity at which two peaks could be distinguished.
Experiments were duplicated at low intensities when the peaks were not
apparent.
RNA isolation and microarray analysis
We isolated cochlea from 64 HMDP strains (2–4 mice per strain) mice
at age 6 wk. RNA was purified after decapitation, the inner ear was
microdissected, all soft tissue was removed from the cochlear capsule,
and the vestibular labyrinth was removed at the level of the round and
oval windows. The microdissected cochleae were frozen in liquid ni-
trogen, ground to powder under liquid nitrogen, and RNA lysis buffer
was added (Ambion). The sample was incubated over night at 4,
centrifuged at 12,000 · g for 5 min to pellet insoluble materials, and
RNA was isolated following manufacturer’s recommendations. This
procedure yielded approximately 300 ng of total RNA per animal. Gene
expression data were generated using Illumina’s Mouse whole genome
expression BeadChips (MouseRef-8-v1 Expression BeadChip). All am-
plifications and hybridizations were performed according to Illumina’s
protocol by the Southern California Genome Consortium microarray
core laboratory at UCLA. In brief, 100 ng of total RNA was reverse-
transcribed to cDNA using Ambion cDNA synthesis kit AMIL1791
and then converted to cRNA and labeled with biotin. Then, 800 ng of
biotinylated cRNA product was hybridized to prepared whole genome
arrays and allowed to incubate overnight (16–20 hr) at 55. Arrays were
n Table 1 Loci identified in HMDP for ABR thresholds at various tone burst frequencies
Trait Chr Position (bp) Lead SNP 95% CI (Mb) Candidate Gene(s) MAF P
4 kHz 3 52509617 rs30259360 51.2, 54.8 Gm2447 0.50 1.3·1025
9 122415312 rs33514183 121.1, 123.7 Higd1a-Ccbp2-Ano10 0.39 9.931027
19 10834438 rs30354441 9.5, 11.1 Prfp19-A430093F15Rik 0.06 1.131027
8 kHz 3 52509617 rs30259360 51.2, 54.8 Gm2447 0.50 3.2·1025
10 91728327 rs38135766 90.4, 93.0 Gm20757 0.28 1.231026
19 10834438 rs30354441 9.5, 11.1 Prfp19-A430093F15Rik 0.06 9.931028
12 kHz 3 52509617 rs30259360 51.2, 54.8 Gm2447 0.50 1.431026
13 63603934 rs51991909 62.3, 64.9 Fbp1-Fancc-Ptch1 0.28 9.631027
19 11217919 rs36642183 9.9, 12.5 Ms4a6d 0.18 4.131026
16 kHz 10 107329794 rs29362366 9.4, 12.0 Otogl/Gm6924 0.28 2.331027
13 63391591 rs13481847 62.0, 64.6 Fbp1-Fancc-Ptch1 0.33 4.3·1025
24 kHz 3 52509617 rs30259360 51.2, 54.8 Gm2447 0.50 7.4·1025
13 63391591 rs13481847 62.0, 64.6 Fbp1-Fancc-Ptch1 0.33 2.231026
13 101851306 rs52344209 100.5, 103.1 Naip2 0.44 3.831027
3 52509617 rs30259360 51.2, 54.8 Gm2447 0.50 1.6·1024
32 kHz 4 85925264 rs28095334 84.6, 87.2 Adamtsl1 0.22 9.731027
13 101851306 rs52344209 100.5, 103.1 Naip2 0.44 1.331026
P values exceeding the genome-wide significance threshold (4.1·1026) are shown in bold. Intervals spanning the 95% confidence interval (CI) are given based on
previous simulation studies in the HMDP (Bennett et al. 2010). Chr, chromosome; MAF, minor allele frequency; BP, base pair position of lead SNP given according to
NCBI build 37 of the reference mouse genome sequence.
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washed and then stained with Cy3-labeled streptavadin. Excess stain
was removed by washing and the arrays were dried and scanned on an
Illumina BeadScan confocal laser scanner.
Association analyses for hearing phenotypes and
tissue eQTLs
For eQTLs in the liver, we used previously generated expression data in
the HMDP (http://geneeqtl.genetics.ucla.edu/).
GWAS analyses for transcript abundance in the cochlea and hearing
phenotypes in the HMDP strains were performed using genotypes of
450,000 SNPs obtained from the Mouse Diversity Array (Yang et al.
2009). SNPs were required to have minor allele frequencies .5% and
missing genotype frequencies ,10%. Applying these filtering criteria
resulted in a final set of 200,000 SNPs that were used for analysis.
Association testing was performed using FaST-LMM (Lippert et al.
2011), a linear mixed model method that is fast and able to account
for population structure. To improve power, when testing all SNPs on
a specific chromosome, the kinship matrix was constructed using the
SNPs from all other chromosomes. This procedure includes the SNP
being tested for association in the regression equation only once.
Genome-wide significance threshold in the HMDP was determined
by the family-wise error rate (FWER) as the probability of observing
one or more false positives across all SNPs per phenotype. We ran 100
different sets of permutation tests and parametric bootstrapping of size
1000 and observed that the genome-wide significance threshold at
a FWER of 0.05 corresponded to P=4.1·1026, similar to what has been
used in previous studies with the HMDP (Ghazalpour et al. 2012). This
is approximately an order of magnitude larger than the threshold
obtained by Bonferroni correction (4.6·1027), which would be an
overly conservative estimate of significance because nearby SNPs
among inbred mouse strains are highly correlated with each other.
Data availability
Strains and genotype data are available from Jackson Labs (http://jax.
org).
RESULTS
Variation in ABR thresholds in the HMDP
As part of our effort to comprehensively characterize the genetic basis
of strain variation in hearing, we recorded ABR threshold data in 5- to
6-wk-old femalemice from29commoninbred (CI) and70recombinant
inbred (RI)mouse strains from theHMDP. Figure 1, A–F demonstrates
the results for ABR thresholds after tone burst stimuli of 4, 8, 12, 16, 24,
and 32 kHz in the HMDP. Notably, among the 99 strains characterized,
ABR across the frequencies tested varied by two-fold to five-fold, strongly
suggesting a complex underlying genetic architecture. Furthermore,
ABR thresholds were highly correlated, particularly among those across
frequencies at the same range of the spectrum (Supporting Information,
Figure S1, Figure S2).
GWAS for ABR threshold variation at each
tested frequency
Based on the phenotypic data in the HMDP, we next sought to identify
the genetic factors affecting hearing by performing a GWAS for ABR
thresholds at each toneburst stimulus frequency.These analyses usedan
efficient mixed model algorithm (EMMA) that takes into account the
underlying population structure and genetic relatedness of the HMDP
strains (Kang et al. 2008) and has been used successfully for association
mapping in the HMDP. These GWAS analyses yielded several inter-
esting observations (Figures 2, A–2F.) First, we identified at least one
locus for each frequency that achieved genome-wide significance, with
a total of nine regions distributed on chromosomes 3, 4, 9, 10, 13, and
19 (Table 1). Second, with the exception of the 24 kHz stimulus, each
analysis identified at least one locus that was frequency-specific. Third,
a locus on chromosome 3 (rs30259360) that was significantly associated
with ABR threshold after a 12-kHz stimulus also demonstrated a sug-
gestive association (P1025) with nearly all other ABR traits (Table 1).
Fourth, loci that were associated with ABR threshold across multiple
frequencies tended to cluster at the same end of the spectrum. For
example, the chromosome 19 locus (rs30354441) that was associated
with ABR threshold after a 4-kHz tone burst also demonstrated asso-
ciation after the 8-kHz stimulus but not the other frequencies. Con-
versely, a locus on chromosome 13 (rs52344209) was only common to
ABR threshold after 24-kHz and 32-kHz tone bursts. Finally, one locus
on chromosome 10 (rs29362366), which was associated with ABR
threshold only after a 16-kHz stimulus, maps to Otogl, a gene that
has been implicated in a Mendelian form of human deafness (Yariz
et al. 2012).
Bioinformatics analyses to prioritize positional
candidate genes
Wenext used bioinformatics approaches toprioritize candidate genes at
each locus. First, we used publicly available expression data for several
tissues in the HMDP (http://geneeqtl.genetics.ucla.edu/) to determine
whether variation at the identified loci had cis-acting effects on gene
expression. Expression QTL (eQTL) were considered local, or cis, if the
lead SNP mapped within 2 Mb of the peak GWAS SNP. We identified
four genes as having cis eQTL in the liver: three (Higd1a, Ccbp2, and
Ano10) are located in the chromosome 9 locus identified in the 4-kHz
GWAS, and the fourth cis eQTL in liver is Naip2, which is located
within the second chromosome 13 region that was identified in the
24 kHz GWAS (Table 2).
n Table 2 cis eQTL for GWAS Loci at Various Tone Burst Frequencies
Trait Chr Lead SNP BP Nearest Genes eQTL Lead SNP eQTL SNP Position eQTL P eQTL Tissue
4 kHz 9 rs33514183 122415312 Higd1a rs13459114 121825029 8.2·10220 Liver
9 rs33514183 122415312 Ccbp2 rs6299531 122834341 2.0·1026 Liver
9 rs33514183 122415312 Ano10 rs3713370 122186398 1.8·10211 Liver
19 rs30354441 10834438 Prpf19 rs30899404 10148177 2.7·1026 Cochlea
8 kHz 19 rs30354441 10834438 Prpf19 rs30899404 10148177 2.7·1026 Cochlea
12 kHz 19 rs36642183 11217919 Ms4a6d rs30768936 11377515 2.7·1028 Cochlea
24 kHz 13 rs13481847 63391591 Fbp1 rs13481847 63290283 6.1·10221 Cochlea
13 rs52344209 101851306 Naip2 rs3144793 100956146 2.4·10211 Liver
Genomic regions 61 Mb around the peak SNPs for each frequency were interrogated for the presence of cis eQTLs in multiple tissues using the UCLA Systems
Genetics Resource (http://systems.genetics.ucla.edu/) and microarray data from cochlear tissue. Only genes exhibiting cis eQTLs in cochlea and liver are listed. Chr,
chromosome; MAF, minor allele frequency; BP, base pair position of lead SNP given according to NCBI build 37 of the reference mouse genome sequence.
Volume 5 November 2015 | Genetics of Hearing in Mice | 2335
Because we are interested in hearing, we wanted to interrogate if any
of our genes exhibit cis eQTL in a more relevant tissue, namely, the
cochlea. Therefore, we performed association analysis on microarray-
generated expression data in the cochlea from a subset of 64 HMDP
strains. Notably, several of our GWAS loci exhibited cis eQTL in co-
chlear tissue (Table 2). For example, Prpf19, whichmaps approximately
700 kb upstream of our peak GWAS SNP for ABR thresholds after
4 kHz and 8 kHz stimuli, yielded a significant eQTL in the cochlea
(rs30899404; P=2.7·1026) but not in other tissues. Additionally, an
eQTL for Ms4a6d (rs30768936; P=2.7·1028) was located 160 kb
downstream of our peak GWAS SNP for the 12-kHz burst in a different
region on chromosome 19 (Table 2). Finally, Fbp1 had a highly signif-
icant cis eQTL (rs13481847; P=6.1·10221) in the cochlea that maps
100 kb upstream of our peak GWAS SNP on chromosome 13 for
ABR threshold after a 24-kHz tone burst. We also examined in situ
imaging to visualize where in the P1mouse cochleaPrpf19 and Fbp1 are
expressed (Figure 3), as expression in different regions of the organ can
indicate different biological functions with respect to hearing. The
sensory epithelium and spiral ganglion demonstrate Prpf19 mRNA
expression (Figure 3A); further, Fbp1 mRNA expression was detected
in the basal layer of the striavascularis in P1mouse cochleae (Figure 3B).
In addition to eQTL analysis, we also used the Ensembl genome
browser to determine whether any of the positional candidate genes
harbored amino acid substitutions among the inbredmouse strains that
were sequenced. Of the candidate genes examined, Otogl had an
Asn2170Ser polymorphism that was predicted to have functionally
deleterious consequences by both SIFT (score = 0.0) and PolyPhen2
(score = 1.0). Otogl is 87% identical to the human protein at the amino
acid level and Asn2170Ser is located in a region of high homology that
is evolutionarily conserved across seven mammalian species (data
not shown). Further analysis revealed that Otogl harbored four addi-
tional amino acid substitutions (Ser177Leu, Ala833Thr, Met1107Ile,
Ser1258Pro) among the available inbred strains, but these were similar
in their physiochemical properties, computationally predicted by SIFT
to be tolerated, or were located in regions of the protein that were not
as evolutionarily conserved as the region containing Asn2170Ser (data
not shown).
Based on these data, we reasoned that one or more of these variants
may be driving the association signal for ABR at 16 kHz at the Otogl
locus. Because none of the five amino acid substitutions were included
in the panel of SNPs used in our GWAS analyses, we used the publicly
available sequence data for 25 inbred strains to determine the extent
of linkage disequilibrium (LD) between the variants and the peakOtogl
SNP (rs29362366). This analysis revealed that the Ser177Leu and
Ala833Thr variants were in perfect LD with rs29362366, whereas
Met1107Ile and Ser1258Pro were much more weakly linked. The
Asn2170Ser polymorphism was also only present in strain DBA/2J.
Thus, the association at Otogl could be due the Ser177Leu and
Ala833Thr variants, even though they were not predicted to have func-
tional effects, or other unknown polymorphisms that are present on
the haplotype containing Ser177Leu, Ala833Thr, and rs29362366. Al-
ternatively, the association signal could be due to the segregation of
Asn2170Ser among DBA and the BXD RI strains. To distinguish be-
tween these possibilities, we performed an association analysis with
rs29362366 with and without DBA/2J and the BXD strains. Notably,
exclusion of these strains increased the significant association of
rs29362366 with ABR at 16 kHz by one order of magnitude
(P=2.5·1028) compared to the analysis that included all HMDP strains
(P=2.3·1027) (Figure 4). Conversely, rs29362366 was not associated
with ABR at 16 kHz in an analysis that included only C57BL/6J, DBA/2J,
and the BXD strains (Figure 4). Taken together, these results suggest
that the association signal at the Otogl locus is due to the haplotype
harboring Ser177Leu, Ala833Thr, and rs29362366.
DISCUSSION
We have used a GWAS approach with correction for population struc-
ture to map several loci for hearing traits in inbred strains of mice. Our
results identify a number of novel loci and demonstrate two critical
additions to the literature. First, with the exception of the Otogl locus,
which was identified in humans, none of the loci identified in the
GWAS with the HMDP overlap with Mendelian loci identified for
hearing loss in mice. This observation supports the notion that varia-
tion in hearing among inbred mouse strains has a complex genetic
architecture. Second, just as the cochlea has a frequency-specific func-
tional placemap, we demonstrate that the genetics of hearing sensitivity
is frequency-specific as well.
We recently published the firstmeta-analysis for age-related hearing
loss in mice using data from several data sets, including a subset of the
HMDP strains (Ohmen et al. 2014). The meta-analysis identified five
significantly associated loci, including Fscn2, the causative gene at the
Figure 3 In situ images exhibiting cochlear mRNA expression of
GWAS candidate genes. (A) Antisense RNA probe for Prpf19 in P1
cochlea demonstrates expression in the cochlear epithelium, repre-
sented by the black circle, and spiral ganglion, denoted by the black
arrow. Stria vascularis indicated by the yellow star. (B) Antisense RNA
probe for Fbp1 in P1 cochlea demonstrates expression in the basal
layer of the stria vascularis, represented by the black oval.
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Ahl8 locus identified in a cross between the DBA/2J and C57BL/6J
strains. However, there was no overlap between the loci detected in
the meta-analysis and those in the present study. For example, the
meta-analysis contained only 35 of the 99 HMDP strains and predom-
inantly powered by the inclusion of N2mice from aDBA/2J ·C57BL/6J
backcross generated by Johnson et al. (2008). By contrast, the present
study sought to identify the genetic determinants for common forms of
hearing with the entire HMDP and would thus be more likely to detect
allelic variation that is present across all 99 strains. Finally, our current
study assessed hearing at 4- and 24-kHz tone burst stimuli, in addition
to those at 8, 16, and 32 kHz that were used in our prior study.
There exists frequency-specific genetic variation in
hearing thresholds in inbred strains of mice
One of the most important findings from our analysis is the apparent
existenceof strong frequency-specific genetic variation in hearing ability
across inbred mouse strains. Ruben demonstrated through an autora-
diographic study of the mouse cochlea that terminal mitoses in the
developing cochlear epithelium were first detected in the cochlear apex
(Ruben 1967). From this study it was concluded that the differentiation
of the cochlear organ of Corti occurred from the base to the apex. The
mammalian cochlea has numerous specializations throughout its length
that contribute to the tonotopic representation of perceived sound with
the basal portion responding to higher frequencies than the apex (Davis
2003; Mann and Kelley 2011). Critical to the frequency tuning of the
cochlea are the morphological and mechanotransductional properties
of the hair cells, the basilar membrane, and the spiral ganglion neurons
along the length of the cochlear spiral. The molecular bases for these
tonotopical specifications along the longitudinal axis of the cochlea
remain largely unknown.
The initial observations made by Zheng et al. (1999) that different
strains exhibit different threshold sensitivities to particular stimulus
frequencies were poignant and were a preliminary insight into the
strain variation and genetic variation of sensitivities along the length
of the cochlear duct. Son et al. (2012), using microarray technology,
also demonstrated gradients of gene expression in the adult and de-
veloping mouse cochlea, a subset of which (approximately 5% of those
genes assayed) exhibited clear spatial and temporal variations in expres-
sion along the cochlear duct. Utilizing an association-based approach,
we build on these prior studies to elucidate the genetic architecture of
hearing sensitivities along the length of the cochlear duct in inbred
strains of mice. For example, the finding of at least one specific genome-
wide significant locus for each frequency in our comprehensive analysis
supports this notion. This was true for each tone-burst stimulus tested
except 24 kHz. Additional support for frequency-specific, or cochlear
regionally specific, genetic determinants comes from the identification
of a locus for the lower-frequency apical cochlear spectrum on chro-
mosome 19 (4 kHz and 8 kHz) and of a region on chromosome 13 for
the higher frequency basilar cochlear spectrum (24 kHz and 32 kHz).
Although a portion of this frequency-specific genetic association can be
explained by issues related to study power, we also detected a genome-
wide significant locus on chromosome 3 for the 12-kHz tone burst that
demonstrated a suggestive association with nearly all other ABR stim-
ulus traits (P1025).
Relationship to alternate forms of hearing loss
To date, approximately 18 loci for AHL and noise-induced hearing loss
(NIHL) have been described in mice using traditional QTL mapping
strategies (http://hearingimpairment.jax.org/table2.html). However,
none of the loci we identified overlap with these previously identified
regions. There may be several reasons for this observation. First, we
tested ABR in mice only at age 5 wk, and many strains used in the
previously reported AHL mapping studies do not develop hearing loss
until a later age; thus, we would not detect impaired hearing in these
strains at 5 wk. Second, prior QTL studies were performed using F2
crosses of two strains of mice, resulting in approximately 50% fre-
quency of each allele in the population of mice for mapping. With
the HMDP, however, the effect allele may not be frequent enough
among the strains used to provide sufficient power with the linear
mixed model mapping algorithm. Despite the limited overlap between
previously reported mouse hearing QTL and the association signals in
this study, our results may still have clinical relevance and do suggest
a connection with hearing phenotypes in humans. For example, bio-
informatics and stratified genetic analyses at the chromosome 10 locus
implicated Otogl as a strong positional candidate for ABR threshold
after a 16-kHz stimulus in the HMDP. Interestingly, mutations of
the human ortholog, OTOGL, have been identified as the cause of
Mendelian forms of moderate high-frequency nonsyndromic hearing
loss in humans (Yariz et al. 20120; Bonnet et al. 2013).
Hearing impairment in mice: natural variation
Our GWAS for hearing phenotypes in mice revealed nine statistically
significant candidate loci; of these, bioinformatic analysis suggests
prioritizing at least four positional candidate genes for functional
validation. As described above, Otogl is a strong candidate for the
Figure 4 ABR at 16 kHz varies by genotype at rs29362366. (A–C) The effect of Otogl peak SNP rs29362366 on 16 kHz ABR. (A) Genotype effect
when all strains are included in analysis. (B) Genotype effect when DBA/2J and BXD RI strains derived from C57BL/6J and DBA/2J matings are
excluded from analysis. (C) Genotype effect when only C57BL/6J, DBA/2J, and BXD RI strains are included in analysis. Haplotype containing allele
C is present in C57BL/6J and haplotype containing allele T is present in DBA/2J.
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16-kHz locus and, based on cochlear eQTL analyses, Prpf19, Ms4a6d,
and Fbp1 represent strong candidates within their respective intervals.
Prpf19 is a pre-mRNA processing factor that has been implicated in
mammalian DNA repair (Mahajan and Mitchell 2003) but has no
known function in the auditory system. Consistent with the eQTL
results, RNAseq data demonstrate a two-fold greater expression level
in cochlear hair cells compared to nonsensory cells (N. Segil, personal
communication) and our in situ data indicate expression in the sensory
epithelium and spiral ganglion. Array data similarly confirms two-fold
greater expression of Prpf19 mRNA in the spiral ganglion neurons of
mice in comparison to the vestibular ganglion beginning at E16 and ex-
tending into adulthood (http://goodrichlabmicroarrays.hms.harvard.edu).
Ms4a6d is a member of a multigene four-transmembrane family
related to CD20, a hematopoietic cell–specific protein and a high-
affinity IgE receptor beta chain (Ishibashi et al. 2001) with no known
function in the mammalian auditory system. Ms4a6d demonstrates
nearly four-fold greater levels of expression in nonsensory cells of the
inner ear and similar expression levels in the spiral and vestibular
ganglia that peak more than 2 wk postnatal, near the time of onset of
hearing in mice (N. Segil, personal communication).
Fbp1 has recently been demonstrated to localize within the cell
nucleus in a cell cycle–dependent manner and may be involved in
RNA processing, nucleosome assembly, and cell cycle regulation. Like
the other putative positional genes described above, it has no known
role in hearing in mammals (Mamczur et al. 2012). RNAseq data also
revealed a two-fold greater expression of this gene in nonsensory cells
of the inner ear and variable levels of expression within the spiral and
vestibular ganglia of mice during prenatal and postnatal periods); ad-
ditionally, our in situ data place Fbp1 mRNA in the striavascularis,
which is critical to the maintenance of the endocochlear potential.
Although a specific function has not been ascribed to the basal cell
layer, there are widespread gap junctions between the basal cells and
the basal cells and intermediate cells. This suggests that these cells make
up a functional syncytium similar to that seen in the myocardium,
supporting the notion that this gene may play a role in hearing in mice.
Taken together, these results demonstrate that Prpf19, Ms4a6d, and
Fbp1 are expressed in various cochlear cell types and that the loci
harboring these genes contain functional genetic variation with respect
to their expression. Additional functional studies will be required to
determine whether these genes play a role in mammalian hearing.
In conclusion, we have performed a comprehensive analysis in mice
to elucidate the genetic architecture of hearing in response to tone burst
stimuli. We identified multiple novel loci that are, for the most part,
frequency-specific and illustrate the complex nature of mammalian
hearing. By combining systems genetics with bioinformatics, we have
also identifiedplausiblepositional candidategenes at several loci that can
be pursued for functional validation. Importantly, the overlap between
the effect of the Otogl locus on hearing loss in mice and nonsyndromic
hearing loss in humans reinforces the concept that the underlying bio-
logical pathways are likely to be conserved among mammals. Further-
more, the results of such genetic studies in mice can potentially be
leveraged toward development of novel prevention and treatment
strategies.
ACKNOWLEDGMENTS
This work was supported by California Institute for Regenerative
Medicine grant TG2-01161 (A.L.C.); NIH grants T32ES013678 (A.L.C.),
R01ES022282 (E.E.), P01HL30568 (A.J.L.), P01HL28481 (A.J.L.),
R01ES021801 (H.A.), 3R01ES021801-03S1 (H.A.), R01ES025786
(H.A.), and R01DC010856 (R.A.F.); pilot project awards from the
Southern California Clinical and Translational Science Institute
through NIH grant UL1TR000130 (H.A.) and the Southern California
Environmental Health Sciences Center through NIH grant
P30ES007048 (H.A.). The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the
manuscript.
LITERATURE CITED
Bennett, B. J., C. R. Farber, L. Orozco, H. M. Kang, A. Ghazalpour et al.,
2010 A high-resolution association mapping panel for the dissection of
complex traits in mice. Genome Res. 20: 281–290.
Bonnet, C., M. Louha, N. Loundon, N. Michalski, E. Verpy et al.,
2013 Biallelic nonsense mutations in the otogelin-like gene (OTOGL)
in a child affected by mild to moderate hearing impairment. Gene 527:
537–540.
Davis, R. L., 2003 Gradients of neurotrophins, ion channels, and tuning in
the cochlea. Neuroscientist 9: 311–316.
Flint, J., and E. Eskin, 2012 Genome-wide association studies in mice. Nat.
Rev. Genet. 13: 807–817.
Fransen, E., S. Bonneux, J. J. Corneveaux, I. Schrauwen, F. Di Berardino et al.,
2015 Genome-wide association analysis demonstrates the highly
polygenic character of age-related hearing impairment. Eur. J. Hum.
Genet. 23: 110–115.
Friedman, R. A., L. Van Laer, M. J. Huentelman, S. S. Sheth, E. Van Eyken
et al., 2009 GRM7 variants confer susceptibility to age-related hearing
impairment. Hum. Mol. Genet. 18: 785–796.
Ghazalpour, A., C. D. Rau, C. R. Farber, B. J. Bennett, L. D. Orozco et al.,
2012 Hybrid mouse diversity panel: a panel of inbred mouse strains
suitable for analysis of complex genetic traits. Mamm. Genome 23:
680–692.
Huang, Q., and J. Tang, 2010 Age-related hearing loss or presbycusis. Eur.
Arch. Otorhinolaryngol. 267: 1179–1191.
Ishibashi, K., M. Suzuki, S. Sasaki, and M. Imai, 2001 Identification of
a new multigene four-transmembrane family (MS4A) related to CD20,
HTm4 and beta subunit of the high-affinity IgE receptor. Gene 264:
87–93.
Johnson, K. R., C. Longo-Guess, L. H. Gagnon, H. Yu, and Q. Y. Zheng,
2008 A locus on distal chromosome 11 (ah18) and its interaction
Cdh23 ahl underlie the early, age-related hearing loss of DBA/2J mice.
Genomics 94(4): 219–225.
Kang, H. M., N. A. Zaitlen, C. M. Wade, A. Kirby, D. Heckerman et al.,
2008 Efficient control of population structure in model organism
association mapping. Genetics 178: 1709–1723.
Lindblad-Toh, K., E. Winchester, M. J. Daly, D. G. Wang, J. N. Hirschhorn
et al., 2000 Large-scale discovery and genotyping of single-nucleotide
polymorphisms in the mouse. Nat. Genet. 24: 381–386.
Lippert, C., J. Listgarten, Y. Liu, C. M. Kadie, R. I. Davidson et al.,
2011 FaST linear mixed models for genome-wide association studies.
Nat. Methods 8: 833–835.
Mahajan, K. N., and B. S. Mitchell, 2003 Role of human Pso4 in mam-
malian DNA repair and association with terminal deoxynucleotidyl
transferase. Proc. Natl. Acad. Sci. USA 100: 10746–10751.
Mamczur, P., A. J. Sok, A. Rzechonek, and D. Rakus, 2012 Cell cycle-
dependent expression and subcellular localization of fructose
1,6-bisphosphatase. Histochem. Cell Biol. 137: 121–136.
Mann, Z. F., and M. W. Kelley, 2011 Development of tonotopy in the
auditory periphery. Hear. Res. 276: 2–15.
Mott, R., and J. Flint, 2013 Dissecting quantitative traits in mice. Annu.
Rev. Genomics Hum. Genet. 14: 421–439.
Ohmen, J., E. Y. Kang, X. Li, J. W. Joo, F. Hormozdiari et al., 2014 Genomic-
wide association study for age-related hearing loss (AHL) in the mouse:
a meta-analysis. J. Assoc. Res. Otolaryngol 15(3): 335–352.
Ruben, R. J., 1967 Development of the inner ear of the mouse: a radioauto-
graphic study of terminal mitoses. Acta Otolaryngol. Suppl. 220: 221–244.
Son, E. J., L. Wu, H. Yoon, S. Kim, J. Y. Choi et al., 2012 Developmental
gene expression profiling along the tonotopic axis of the mouse cochlea.
PLoS One 7(7): e40735.
2338 | A. L. Crow et al.
Valdar, W., L. C. Solberg, D. Gauguier, S. Burnett, P. Klenerman et al.,
2006 Genome-wide genetic association of complex traits in heterogeneous
stock mice. Nat. Genet. 38: 879–887.
Welter, D., J. MacArthur, J. Morales, T. Burdett, P. Hall et al., 2014 The
NHGRI GWAS Catalog, a curated resource of SNP-trait associations.
Nucleic Acids Res. 42(Database issue): D1001–D1006.
Wiltshire, T., M. T. Pletcher, S. Batalov, S. W. Barnes, L. M. Tarantino et al.,
2003 Genome-wide single-nucleotide polymorphism analysis defines
haplotype patterns in mouse. Proc. Natl. Acad. Sci. USA 100: 3380–3385.
Yalcin, B., J. Fullerton, S. Miller, D. A. Keays, S. Brady et al., 2004 Unexpected
complexity in the haplotypes of commonly used inbred strains of laboratory
mice. Proc. Natl. Acad. Sci. USA 101: 9734–9739.
Yang, H., Y. Ding, L. N. Hutchins, J. Szatkiewicz, T. A. Bell et al., 2009 A
customized and versatile high-density genotyping array for the mouse.
Nat. Methods 6: 663–666.
Yariz, K. O., D. Duman, C. Z. Seco, J. Dallman, M. Huang et al.,
2012 Mutations in OTOGL, encoding the inner ear protein otogelin-like,
cause moderate sensorineural hearing loss. Am. J. Hum. Genet. 91:
872–882.
Zheng, Q. Y., K. R. Johnson, and L. C. Erway, 1999 Assessment of hearing in
80 inbred strains of mice by ABR threshold analyses. Hear Res. 130(1–2):
94–107.
Communicating editor: D. W. Threadgill
Volume 5 November 2015 | Genetics of Hearing in Mice | 2339
